W. A. Dengler - Concepedia

Author

W. A. Dengler

Also Known As

Dengler, Wolfgang A., W A Dengler, W Dengler, W. A. Dengler, W. Dengler, W.A. Dengler, Wolfgang A Dengler, Wolfgang Dengler

Publications

811

Citations

H-Index

Concepts

All Affiliations

University of Freiburg University Medical Center Freiburg

About

W. A. Dengler is an author at University of Freiburg specializing in tumor microenvironment, tumor biology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	353
2	Cell Biology	3	3	278
3	Immunology	2	2	70
4	Obstetrics	1	1	21
5	Pathology	1	1	89

W. A. Dengler

Publications

646

Citations

H-Index

Page 1

	Year	Citations
Development of a propidium iodide fluorescence assay for proliferation and cytotoxicity assays W. A. Dengler, Dietmar Berger, R Mertelsmann, Anti-Cancer Drugs	1995	260
Flavopiridol (L86-8275): selective antitumor activity in vitro and activity in vivo for prostate carcinoma cells. Markus Drees, W. A. Dengler, Thomas Roth, PubMed Tumor XenograftsAntitumor ActivityPharmacotherapySelective Antitumor ActivityHuman Tumor Xenografts	1997	140
Vascular endothelial growth factor (VEGF) mRNA expression in human tumor models of different histologies Dietmar Berger, L. Herbstritt, W. A. Dengler, Annals of Oncology Mrna ExpressionAngiogenesisMedicinePathologyVascular Biology	1995	89
Combined In Vitro/In Vivo Test Procedure with Human Tumor Xenografts for New Drug Development Heinz‐Herbert Fiebig, Dietmar Berger, W. A. Dengler, Beiträge zur Onkologie/Contributions to oncology XenotransplantationOncologyHuman Tumor XenograftsMedicineTheranostics	1992	54
Targeted inhibition of tumor‐cell growth by recombinant heregulin‐toxin fusion proteins Margit Jeschke, Winfried S. Wels, W. A. Dengler, International Journal of Cancer Functional DomainsMedicineTumor‐cell GrowthImmunologyCancer Growth	1995	49
No evidence of tumor growth stimulation in human tumors in vitro following treatment with recombinant human growth hormone Heinz‐Herbert Fiebig, W. A. Dengler, Hans R. Hendriks Anti-Cancer Drugs Human GrowthImmunologyGynecologyTumor Growth EnhancementTumor Biology	2000	21
Processing of Tumor Tissues for Vaccination with Autologous Tumor Cells Michael Lahn, Gabriele K ouml hler, Claudia Schmoor, European Surgical Research	1997	13
Preclinical activity off hepsulfam and busulfan in solid human tumor xenografts and human bone marrow Dietmar Berger, B. R. Winterhalter, W. A. Dengler, Anti-Cancer Drugs	1992	10
Intra-tumoral application of a heregulin-exotoxin-A fusion protein causes rapid tumor regression without adverse systemic or local effects Bernd Groner, B. Wick, Margit Jeschke, International Journal of Cancer	1997	10

Page 1